Research Project
RP-1626-QLG
Predictors of quality of life ratings from patients with primary brain tumors: the role of self-awareness and cognitive functioning
Project Status
Ongoing
Dates
Project start date: 12-Apr-2016
Type Data
QoL Data
Type Research
QLG-funded research
Participating groups
- EORTC Quality of Life Group
Project Leads
- Dr. Jaap Reijneveld (Amsterdam UMC - locatie VUMC - Netherlands)
- Dr. Martin Klein (Amsterdam UMC - locatie VUMC - Netherlands)
Linked Studies
EORTC-26091
Randomized trial assessing the significance of Bevacizumab in recurrent grade II and Grade III gliomas: The TAVAREC trial.
EORTC-26951
Phase III study of adjuvant Procarbazine, CCNU and Vincristine chemotherapy
in patients with highly anaplastic oligodendroglioma (randomized)
EORTC-26981-22981
"Concomitant and adjuvant Temozolomide and Radiotherapy for newly diagnosed
glioblastoma multiforme. A randomized phase III study"
EORTC-26101
Phase III trial exploring the combination of bevacizumab and lomustine in patients with first recurrence of a glioblastoma – previously: Phase II trial exploring the sequence of bevacizumab and lomustine in patients with first recurrence of a glioblastoma
EORTC-22033-26033-ROG-BTG
Primary chemotherapy with temozolomide vs.radiotherapy in patients with low grade gliomas after stratification for genetic 1p loss : a phase III study
EORTC-26053-22054
Phase III trial on concurrent and adjuvant temozolomide chemotherapy in non-1p/19q deleted anaplastic glioma. The CATNON intergroup trial.
